抄録
A medical system is anticipated, where high-quality medical services are accessible without anxieties whenever we are ill or injured. The innovative regenerative medical products have enabled us to overcome some life threatening diseases, however, challenges still remain for others. The Ministry of Health, Labour and Welfare has implemented "The guideline for clinical research using human stem cells" and has launched on Sept 1, 2006. The major goal of the guideline is to reinforce and ensure safe on investigational new regenerative medical products. In this paper, I will give an overview of the guideline for clinical research using human stem cells, which intends to satisfy unmet medical needs in the field of regenerative medicine as well as to keep medical advances in Japan.
| 本文言語 | 英語 |
|---|---|
| ページ(範囲) | 843-849 |
| ページ数 | 7 |
| ジャーナル | Nippon rinsho. Japanese journal of clinical medicine |
| 巻 | 66 |
| 号 | 5 |
| 出版ステータス | 出版済み - 05-2008 |
UN SDG
この成果は、次の持続可能な開発目標に貢献しています
-
SDG 3 すべての人に健康と福祉を
All Science Journal Classification (ASJC) codes
- 医学一般
フィンガープリント
「An overview of "the guideline for clinical research using human stem cells"」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。引用スタイル
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver